[1]蒋泽文,吕金富,林纯皓,等.131I治疗Graves病合并免疫性血小板减少症1例并文献回顾[J].国际内分泌代谢杂志,2023,43(03):257-260.[doi:10.3760/cma.j.cn121383-20220228-02067]
 Jiang Zewen,Lv Jinfu,Lin Chunhao,et al.Application of 131I to treat Graves' disease complicated with immune thrombocytopenia: A case report and literature review[J].International Journal of Endocrinology and Metabolism,2023,43(03):257-260.[doi:10.3760/cma.j.cn121383-20220228-02067]
点击复制

131I治疗Graves病合并免疫性血小板减少症1例并文献回顾()
分享到:

《国际内分泌代谢杂志》[ISSN:1673-4157/CN:12-1383/R]

卷:
43
期数:
2023年03期
页码:
257-260
栏目:
病例报告
出版日期:
2023-05-20

文章信息/Info

Title:
Application of 131I to treat Graves' disease complicated with immune thrombocytopenia: A case report and literature review
作者:
蒋泽文吕金富林纯皓付巍
桂林医学院附属医院核医学科,桂林 541001
Author(s):
Jiang Zewen Lv Jinfu Lin Chunhao Fu Wei
Department of Nuclear Medicine, Affiliated Hospital, Guilin Medical University, Guilin 541001, China
DOI:
10.3760/cma.j.cn121383-20220228-02067

参考文献/References:

[1] 中华医学会核医学分会.131I治疗格雷夫斯甲亢指南(2021版)[J].中华核医学与分子影像杂志,2021,41(4):242-253.DOI:10.3760/cma.j.cn321828-20201109-00405.
[2] Jackson AS.Acute hemorrhagic purpura associated with exophthalmic goiter[J].JAMA,1931,96:38-39.DOI:10.1001/jama.1931.27220270001012.
[3] Cheung E,Liebman HA.Thyroid disease in patients with immune thrombocytopenia[J].Hematol Oncol Clin North Am,2009,23:1251-1260.DOI:10.1016/j.hoc.2009.08.003.
[4] Segal BM,Weintraub MJ.Hashimoto's thyroiditis, myasthenia gravis,idiopathic thrombocytopenic purpura[J].Ann Intern Med,1976,85(6):761-763.DOI:10.7326/0003-4819-85-6-761.
[5] Kohli RS,Bleibel W,Bleibel H.Concurrent immune thrombocytopenic purpura and Guillain-Barre syndrome in a patient with Hashimoto's thyroiditis[J].Am J Hematol,2007,82(4):307-308.DOI:10.1002/ajh.20771.
[6] Oren ME,Cohen MS.Immune thrombocytopenia,red cell aplasia,lupus,and hyperthyroidism[J].South Med J,1978,71(12):1577-1578.DOI:10.1097/00007611-197812000-00038.
[7] Kamei N,Yamane K,Yamashita Y,et al.Anti-Ku antibody-positive scleroderma-dermatomyositis overlap syndrome developing Graves' disease and immune thrombocytopenic purpura[J].Intern Med,2002,41(12):1199-1203.DOI:10.2169/internalmedicine.41.1199.
[8] Cines DB,Bussel JB,Liebman HA,et al.The ITP syndrome:pathogenic and clinical diversity[J].Blood,2009,113(26):6511-6521.DOI:10.1182/blood-2009-01-129155.
[9] Bizzaro N.Familial association of autoimmune thrombocytopenia and hyperthyroidism[J].Am J Hematol,1992,39(4):294-298.DOI:10.1002/ajh.2830390411.
[10] Eric MC,Rahul N,Michael K,et al.Thyroid disorder-related immune thrombocytopenia:clinical and laboratory characteristics[J].Blood,2008,112(11):4561-4561.DOI:10.1182/blood.V112.11.4561.4561.
[11] Ioachimescu AG,Makdissi A,Lichtin A,et al.Thyroid disease in patients with idiopathic thrombocytopenia:a cohort study[J].Thyroid,2007,17(11):1137-1142.DOI:10.1089/thy.2007.0066.
[12] Liebman H.Other immune thrombocytopenias[J].Semin Hematol,2007,44(4 Suppl 5):S24-S34.DOI:10.1053/j.seminhematol.2007.11.004.
[13] Panzer S,Haubenstock A,Minar E.Platelets in hyperthyroidism:studies on platelet counts,mean platelet volume,111-indium-labeled platelet kinetics,and platelet-associated immunoglobulins G and M[J].J Clin Endocrinol Metab,1990,70(2):491-496.DOI:10.1210/jcem-70-2-491.
[14] Kurata Y,Nishioeda Y,Tsubakio T,et al.Thrombocytopenia in Graves' disease: effect of T3 on platelet kinetics[J].Acta Haematol,1980,63(4):185-190.DOI:10.1159/000207396.
[15] Cordiano I,Betterle C,Spadaccino CA,et al.Autoimmune thrombocytopenia(AITP)and thyroid autoimmune disease(TAD):overlapping syndromes?[J].Clin Exp Immunol,1998,113(3):373-378.DOI:10.1046/j.1365-2249.1998.00677.x.
[16] Altintas A,Pasa S,Cil T,et al.Thyroid and celiac diseases autoantibodies in patients with adult chronic idiopathic thrombocytopenic purpura[J].Platelets,2008,19(4):252-257.DOI:10.1080/09537100801894651.
[17] Herman J,Resnitzky P,Fink A.Association between thyrotoxicosis and thrombocytopenia.a case report and review of the literature[J].Isr J Med Sci,1978,14(4):469-475.
[18] Sugimoto K,Sasaki M,Isobe Y,et al.Improvement of idiopathic thrombocytopenic purpura by antithyroid therapy[J].Eur J Haematol,2005,74(1):73-74.DOI:10.1111/j.1600-0609.2004.00341.x.
[19] Ross DS,Burch HB,Cooper DS, et al.2016 American Thyroid Association Guidelines for diagnosis and management of hyperthyroidism and other causes of thyrotoxicosis[J].Thyroid,2016,26(10):1343-1421.DOI:10.1089/thy.2016.0229.
[20] Shekhda KM.The association of hyperthyroidism and immune thrombocytopenia:are we still missing something?[J].Ci Ji Yi Xue Za Zhi,2018,30(3):188-190.DOI:10.4103/tcmj.tcmj_139_17.
[21] Jung RS,Parghane RV,Sood A,et al.Primary autoimmune thrombocytopenia and co-existing Graves' disease:role of radioiodine-131[J].Indian J Nucl Med,2014,29(3):195-196.DOI:10.4103/0972-3919.136602.
[22] 孟贺利,靳德芬,刘秋萍.抗甲状腺药物引起血小板减少200例分析[J].河南诊断与治疗杂志,2001(04):247-248.DOI:10.3969/j.issn.1674-3474.2001.0405.
[23] Provan D,Arnold DM,Bussel JB,et al.Updated international consensus report on the investigation and management of primary immune thrombocytopenia[J].Blood Adv,2019,3(22):3780-3817.DOI:10.1182/bloodadvances.2019000812.

备注/Memo

备注/Memo:
通信作者:付巍,Email:fuwei19700513@163.com
基金项目:桂林医学院附属医院教职工科研能力提升项目(2019GLMU1A009)
更新日期/Last Update: 2023-05-20